Abstract
Human ABCG2 is an efflux protein belonging to the ATP-binding cassette transporter superfamily. It is expressed in the plasma membrane of different cell types performing various physiological functions. It is the most recently discovered MDR transporter and its structure and function are still not well understood. Thus, expression and functional reconstitution of the protein in different variants and from different sources are important steps for its further investigation. In this work we describe a recombinant synthesis of human ABCG2 R482G from S. cerevisiae. We expressed the human ABCG2 R482G variant in S. cerevisiae and purified the protein from total yeast membranes. Using a panel of sixteen detergents, we analyzed the efficiency of extraction of ABCG2 from membranes by SDS–PAGE and immunoblot analysis. Based on these results, three detergents were selected for further purification studies and two of them, n-octyl-β-D-glucopyranoside and n-dodecyl-β-D-maltopyranoside, yielded functional protein after reconstitution into liposomes. We show here the first example of purified and reconstituted ABCG2 expressed in S. cerevisiae retaining drug-stimulated ATPase activity.
Similar content being viewed by others
Abbreviations
- MDR:
-
Multidrug resistance
- ABC:
-
ATP-binding cassette
- BCRP:
-
Breast cancer resistance protein
- ABCP:
-
Placental ABC protein
- MXR:
-
Mitoxantrone resistance protein
- MRP:
-
Multidrug resistance associated protein
- MM:
-
Minimal media
- PMSF:
-
Phenylmethansulfonyl fluoride
- DFP:
-
Diisopropyl fluorophosphate
- PVDF:
-
Polyvinylidene fluoride
- HRP:
-
Horseradish peroxidase
- Ni-NTA:
-
Ni2+-nitrilotriacetate
- CHAPSO:
-
3-[(3-cholamidopropyl)-dimethylammonio]-2-hydroxy-1-propanesulfonate
- DM:
-
n-decyl-β-D-maltopyranoside
- DDM:
-
n-dodecyl-β-D-maltopyranoside
- OG:
-
n-octyl-β-D-glucopyranoside
- FC-12:
-
Fos-choline 12
- FC-13:
-
Fos-choline 13
- FC-14:
-
Fos-choline 14
- FC-15:
-
Fos-choline 15
- FC-16:
-
Fos-choline 16
- PMA1:
-
Plasma membrane H+-ATPase
- PDR:
-
Pleiotropic drug resistance
- PGK:
-
Phosphoglycerate kinase
References
Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M (1998) Cancer Res 58:5337–5339
Anderson JL, Frase H, Michaelis S, Hrycyna CA (2005) J Biol Chem 280:7336–7345
Bhatia A, Schäfer H, Hrycyna CA (2005) Biochemistry 44:10893–10904
Chen Z, Liu F, Ren Q, Zhao Q, Ren H, Lu S, Zhang L, Han Z (2010) Int J Cancer 126:841–851
Cooray HC, Shahi S, Cahn AP, van Veen HW, Hladky SB, Barrand MA (2006) Eur J Pharmacol 531:25–33
Diop NK, Hrycyna CA (2005) Biochemistry 44:5420–5429
Doyle LA, Ross DD (2003) Oncogene 22:7340–7358
Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD (1998) Proc Natl Acad Sci U S A 95:15665–15670
Dyballa N, Metzger S (2009) J Vis Exp
Ejendal KFK, Diop NK, Schweiger LC, Hrycyna CA (2006) Protein Sci 15:1597–1607
Ejendal KFK, Hrycyna CA (2002) Curr Protein Pept Sci 3:503–511
Evans GL, Ni B, Hrycyna CA, Chen D, Ambudkar SV, Pastan I, Germann UA, Gottesman MM (1995) J Bioenerg Biomembr 27:43–52
Fernandes AR, Sá-Correia I (2003) Yeast 20:207–219
Figler RA, Omote H, Nakamoto RK, Al-Shawi MK (2000) Arch Biochem Biophys 376:34–46
Glavinas H, Kis E, Pál A, Kovács R, Jani M, Vági E, Molnár E, Bánsághi S, Kele Z, Janáky T, Báthori G, von Richter O, Koomen G, Krajcsi P (2007) Drug Metab Dispos 35:1533–1542
Henriksen U, Fog JU, Litman T, Gether U (2005) J Biol Chem 280:36926–36934
Honjo Y, Hrycyna CA, Yan QW, Medina-Pérez WY, Robey RW, van de Laar A, Litman T, Dean M, Bates SE (2001) Cancer Res 61:6635–6639
Ishii M, Iwahana M, Mitsui I, Minami M, Imagawa S, Tohgo A, Ejima A (2000) Anticancer Drugs 11:353–362
Janvilisri T, Venter H, Shahi S, Reuter G, Balakrishnan L, van Veen HW (2003) J Biol Chem 278:20645–20651
Jungwirth H, Kuchler K (2006) FEBS Lett 580:1131–1138
Kage K, Fujita T, Sugimoto Y (2005) Cancer Sci 96:866–872
Kaplan RS, Pedersen PL (1985) Anal Biochem 150:97–104
Litman T, Druley TE, Stein WD, Bates SE (2001) Cell Mol Life Sci 58:931–959
Liu Y, Yang Y, Qi J, Peng H, Zhang J (2008) J Pharmacol Exp Ther 326:33–40
Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, Schellens JH (2001) Cancer Res 61:3458–3464
Mao Q, Conseil G, Gupta A, Cole SPC, Unadkat JD (2004) Biochem Biophys Res Commun 320:730–737
Mao Q, Scarborough GA (1997) Biochim Biophys Acta 1327:107–118
Mao Q, Unadkat JD (2005) AAPS J 7:E118–133
McDevitt CA, Collins RF, Conway M, Modok S, Storm J, Kerr ID, Ford RC, Callaghan R (2006) Structure 14:1623–1632
Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B, Brangi M, Greenberger L, Dean M, Fojo T, Bates SE (1999) Cancer Res 59:8–13
Nakanishi T, Doyle LA, Hassel B, Wei Y, Bauer KS, Wu S, Pumplin DW, Fang H, Ross DD (2003) Mol Pharmacol 64:1452–1462
Oezvegy C, Litman T, Szakács G, Nagy Z, Bates S, Váradi A, Sarkadi B (2001) Biochem Biophys Res Commun 285:111–117
Oezvegy C, Váradi A, Sarkadi B (2002) J Biol Chem 277:47980–47990
Palermo LM, Leak FW, Tove S, Parks LW (1997) Curr Genet 32:93–99
Polgar O, Robey RW, Morisaki K, Dean M, Michejda C, Sauna ZE, Ambudkar SV, Tarasova N, Bates SE (2004) Biochemistry 43:9448–9456
Pozza A, Pérez-Victoria JM, Di Pietro A (2009) Protein Expr Purif 63:75–83
Pozza A, Pérez-Victoria JM, Sardo A, Ahmed-Belkacem A, Di Pietro A (2006) Cell Mol Life Sci 63:1912–1922
Pál A, Méhn D, Molnár E, Gedey S, Mészáros P, Nagy T, Glavinas H, Janáky T, von Richter O, Báthori G, Szente L, Krajcsi P (2007) J Pharmacol Exp Ther 321:1085–1094
Robey RW, Obrzut T, Shukla S, Polgar O, Macalou S, Bahr JC, Di Pietro A, Ambudkar SV, Bates SE (2009) Cancer Chemother Pharmacol 64:575–583
Robey RW, Polgar O, Deeken J, To KW, Bates SE (2007) Cancer Metastasis Rev 26:39–57
Rogers B, Decottignies A, Kolaczkowski M, Carvajal E, Balzi E, Goffeau A (2001) J Mol Microbiol Biotechnol 3:207–214
Rosenberg MF, Bikadi Z, Chan J, Liu X, Ni Z, Cai X, Ford RC, Mao Q (2010) Structure 18:482–493
Ross DD, Yang W, Abruzzo LV, Dalton WS, Schneider E, Lage H, Dietel M, Greenberger L, Cole SP, Doyle LA (1999) J Natl Cancer Inst 91:429–433
Shevchenko A, Wilm M, Vorm O, Mann M (1996) Anal Chem 68:850–858
Shukla S, Robey RW, Bates SE, Ambudkar SV (2006) Biochemistry 45:8940–8951
Sievers JG (2007) University of Bonn
Storch CH, Ehehalt R, Haefeli WE, Weiss J (2007) J Pharmacol Exp Ther 323:257–264
Türk D, Szakács G (2009) Curr Opin Drug Discov Devel 12:246–252
Van Veldhoven PP, Mannaerts GP (1987) Anal Biochem 161:45–48
Wu C, Alman BA (2008) Cancer Lett 268:1–9
Xu J, Liu Y, Yang Y, Bates S, Zhang J (2004) J Biol Chem 279:19781–19789
Acknowledgments
We would like to thank Dr. Jens Meyer for his helpful discussions and suggestions during this work. We also thank Dieter Baumert for excellent technical assistance and Dr. Ilza Pajeva for thoroughly revising the manuscript. This work was supported by the Deutsche Forschungsgemeinschaft (Graduiertenkolleg GRK804).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jacobs, A., Emmert, D., Wieschrath, S. et al. Recombinant Synthesis of Human ABCG2 Expressed in the Yeast Saccharomyces cerevisiae: an Experimental Methodological Study. Protein J 30, 201–211 (2011). https://doi.org/10.1007/s10930-011-9321-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-011-9321-5